Antimicrobial stewardship activities: a survey of Queensland hospitals
Minyon L. Avent A B L , Lisa Hall C D , Louise Davis C , Michelle Allen C D , Jason A. Roberts E F , Sean Unwin G , Kylie A. McIntosh H , Karin Thursky I J , Kirsty Buising I K and David L. Paterson A CA Infection and Immunity Theme, UQ Centre for Clinical Research (UQCCR), Level 8, Building 71/918 Royal Brisbane and Women’s Hospital, Herston, Qld 4006, Australia. Email: david.antibiotics@gmail.com
B Department of Pharmacy, Mater Health Services, South Brisbane, Qld 4101, Australia.
C Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Unit, Queensland Health, Herston, Qld 4006, Australia. Email: l11.hall@qut.edu.au; Louise_Davis@health.qld.gov.au
D Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, Qld, 4059, Australia. Email: m27.allen@qut.edu.au
E Burns Trauma and Critical Care Research Centre, The University of Queensland, Level 3 Ned Hanlon Building, Royal Brisbane and Women’s Hospital, Butterfield St, Herston, Qld 4029, Australia. Email: j.roberts2@uq.edu.au
F Pharmacy Department and Department of Intensive Care Medicine, Level 3 Ned Hanlon Building, Royal Brisbane and Women’s Hospital, Butterfield St, Herston, Qld 4029, Australia.
G Princess Alexandra Hospital, Woolloongabba, Qld 4102, Australia. Email: Sean_Unwin@health.qld.gov.au
H Department of Health, 50 Lonsdale Street, Melbourne, Victoria 3000. Email: Kylie.McIntosh@health.vic.gov.au
I Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, Melbourne, Vic. 3000, Australia. Email: karin.thursky@mh.org.au; Kirsty.Buising@mh.org.au
J Infectious Diseases, MacCallum Cancer Centre, Locked Bag 5 A’Beckett Street, Melbourne, Vic. 8006, Australia.
K Department of Infectious Diseases, Royal Melbourne Hospital, Grattan Street, Parkville, Vic. 3050, Australia.
L Corresponding author. Email: m.avent@uq.edu.au
Australian Health Review 38(5) 557-563 https://doi.org/10.1071/AH13137
Submitted: 10 July 2013 Accepted: 20 August 2014 Published: 5 November 2014
Abstract
Objective In 2011, the Australian Commission on Safety and Quality in Health Care (ACSQHC) recommended that all hospitals in Australia must have an Antimicrobial Stewardship (AMS) program by 2013. Nevertheless, little is known about current AMS activities. This study aimed to determine the AMS activities currently undertaken, and to identify gaps, barriers to implementation and opportunities for improvement in Queensland hospitals.
Methods The AMS activities of 26 facilities from 15 hospital and health services in Queensland were surveyed during June 2012 to address strategies for effective AMS: implementing clinical guidelines, formulary restriction, reviewing antimicrobial prescribing, auditing antimicrobial use and selective reporting of susceptibility results.
Results The response rate was 62%. Nineteen percent had an AMS team (a dedicated multidisciplinary team consisting of a medically trained staff member and a pharmacist). All facilities had access to an electronic version of Therapeutic Guidelines: Antibiotic, with a further 50% developing local guidelines for antimicrobials. One-third of facilities had additional restrictions. Eighty-eight percent had advice for restricted antimicrobials from in-house infectious disease physicians or clinical microbiologists. Antimicrobials were monitored with feedback given to prescribers at point of care by 76% of facilities. Deficiencies reported as barriers to establishing AMS programs included: pharmacy resources, financial support by hospital management, and training and education in antimicrobial use.
Conclusions Several areas for improvement were identified: reviewing antimicrobial prescribing with feedback to the prescriber, auditing, and training and education in antimicrobial use. There also appears to be a lack of resources to support AMS programs in some facilities.
What is known about the topic? The ACSQHC has recommended that all hospitals implement an AMS program by 2013 as a requirement of Standard 3 (Preventing and Controlling Healthcare-Associated Infections) of the National Safety and Quality Health Service Standards. The intent of AMS is to ensure appropriate prescribing of antimicrobials as part of the broader systems within a health service organisation to prevent and manage healthcare-associated infections, and improve patient safety and quality of care. This criterion also aligns closely with Standard 4: Medication Safety. Despite this recommendation, little is known about what AMS activities are undertaken in these facilities and what additional resources would be required in order to meet these national standards.
What does the paper add? This is the first survey that has been conducted of public hospital and health services in Queensland, a large decentralised state in Australia. This paper describes what AMS activities are currently being undertaken, identifies practice gaps, barriers to implementation and opportunities for improvement in Queensland hospitals.
What are the implications for practitioners? Several areas for improvement such as reviewing antimicrobial prescribing with feedback to the prescriber, auditing, and training and education in antimicrobial use have been identified. In addition, there appears to be a lack of resources to support AMS programs in some facilities.
References
[1] Ingram PR, Seet JM, Budgeon CA, Murray R. Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J 2012; 42 719–21.| Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC38jhs1yltg%3D%3D&md5=4b5aa17aae3e203e30d8fed14a92d504CAS | 22697156PubMed |
[2] Gottlieb T, Nimmo GR. Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011. Med J Aust 2011; 194 281–3.
| 21426279PubMed |
[3] van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25 362–86.
| Predictors of mortality in Staphylococcus aureus bacteremia.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XotVSlt7k%3D&md5=a3c9dc52529e2d6da26a37bcba89b543CAS | 22491776PubMed |
[4] Infectious Diseases Society of America (IDSA) Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011; 52 S397–428.
| Combating antimicrobial resistance: policy recommendations to save lives.Crossref | GoogleScholarGoogle Scholar | 21474585PubMed |
[5] Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N’Doye B, Pittet D, Richtmann R, Seto WH, van der Meer JWM, Voss A. Society’s failure to protect a precious resource: antibiotics. Lancet 2011; 378 369–71.
| Society’s failure to protect a precious resource: antibiotics.Crossref | GoogleScholarGoogle Scholar | 21477855PubMed |
[6] MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005; 18 638–56.
| Antimicrobial stewardship programs in health care systems.Crossref | GoogleScholarGoogle Scholar | 16223951PubMed |
[7] Australian Commision on Safety and Quality in Healthcare (ACSQH). National safety and quality health service standards. Sydney: ACSQH; 2011. Available at: http//www.safetyandquality.gov.au/wp-content/uploads/2011/01/NSQHS-Standards-Sept11.pdf [verified 1 September 2014].
[8] Office of Economic and Statistical Research, Queensland Treasury and Trade. Population growth highlights and trends. Brisbane: Queensland Government Statistician’s Office; 2012.
[9] Antibiotic Expert Group. Therapeutic guidelines: antibiotic. 14th edn. Melbourne: Therapeutic Guidelines; 2010.
[10] Trivedi KK, Rosenberg J. The state of antimicrobial stewardship programs in California. Infect Control Hosp Epidemiol 2013; 34 379–84.
| The state of antimicrobial stewardship programs in California.Crossref | GoogleScholarGoogle Scholar | 23466911PubMed |
[11] Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44 159–77.
| Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.Crossref | GoogleScholarGoogle Scholar | 17173212PubMed |
[12] James RS, McIntosh KA, Luu SB, Cotta MO, Marshall C, Thursky KA, Buising KL. Antimicrobial stewardship in Victorian hospitals: a statewide survey to identify current gaps. Med J Aust 2013; 199 692–5.
| Antimicrobial stewardship in Victorian hospitals: a statewide survey to identify current gaps.Crossref | GoogleScholarGoogle Scholar | 24237101PubMed |
[13] Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis 2008; 21 344–9.
| Hospital antibiotic stewardship.Crossref | GoogleScholarGoogle Scholar | 18594284PubMed |
[14] Drew RH, White R, MacDougall C, Hermsen ED, Owens RC. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 2009; 29 593–607.
| Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.Crossref | GoogleScholarGoogle Scholar | 19397466PubMed |
[15] Bal AM, Gould IM. Antibiotic stewardship: overcoming implementation barriers. Curr Opin Infect Dis 2011; 24 357–62.
| Antibiotic stewardship: overcoming implementation barriers.Crossref | GoogleScholarGoogle Scholar | 21587070PubMed |
[16] Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 2009; 30 97–8.
| Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.Crossref | GoogleScholarGoogle Scholar | 19046053PubMed |
[17] Nathwani D. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. J Antimicrob Chemother 2006; 57 1189–96.
| Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28XmsFyktLs%3D&md5=79d84470d3096aab453e8a56f3cd9831CAS | 16624876PubMed |
[18] Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005; 4 CD003543
| 16235326PubMed |
[19] Duguid M, Cruickshank M. Antimicrobial stewardship in Australian hospitals. Sydney: Australian Commission on Safety and Quality on Health Care; 2011. Available at: http://www.safetyandquality.gov.au/wp-content/uploads/2011/01/Antimicrobial-stewardship-in-Australian-Hospitals-2011.pdf [verified 2 September 2014].
[20] Chen AWJ, Khumra S, Eaton V, Kong DCM. Snapshot of barriers to and indicators for antimicrobial stewardship in Australian Hospitals. J Pharm Pract Res 2011; 41 37–41.
[21] Price J, Ekleberry A, Grover A, Melendy S, Baddam K, McMahon J, Villalba M, Johnson M, Zervos MJ. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med 1999; 27 2118–24.
| Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c%2FhsVahug%3D%3D&md5=4c8eb5938d2d5fe0f26c55c9d9078a28CAS | 10548192PubMed |
[22] Martínez R, Reyes S, Lorenzo MJ, Menendez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 2009; 30 172–8.
| Impact of guidelines on outcome: the evidence.Crossref | GoogleScholarGoogle Scholar | 19296417PubMed |
[23] Cruickskank M, Ferguson J, editors. Reducing harm to patients from health care associated infection: the role of surveillance. Sydney: Australian Commission on Safety and Quality in Health Care; 2008.
[24] Grol R, Buchan H. Clinical guidelines: what can we do to increase their use? Med J Aust 2006; 185 301–2.
| 16999667PubMed |
[25] White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25 230–9.
| Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.Crossref | GoogleScholarGoogle Scholar | 9332517PubMed |
[26] Goff DA. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis 2011; 24 S11–20.
| Antimicrobial stewardship: bridging the gap between quality care and cost.Crossref | GoogleScholarGoogle Scholar | 21200180PubMed |
[27] Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med 2011; 6 S4–15.
| Antimicrobial stewardship for inpatient facilities.Crossref | GoogleScholarGoogle Scholar | 21225949PubMed |
[28] Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28 1062–6.
| Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1MznvFOjtg%3D%3D&md5=048125bc7da62f21ca6438261a852a88CAS | 10452635PubMed |
[29] Walbrown MA, Aspinall SL, Bayliss NK, Stone RA, Cunningham F, Squier CL, Good CB. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones. J Manag Care Pharm 2008; 14 34–40.
| 18240880PubMed |
[30] Richards MJ, Robertson MB, Dartnell JG, Duarte MM, Jones NR, Kerr DA, Lim LL, Ritchie PD, Stanton GJ, Taylor SE. Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital. Med J Aust 2003; 178 386–90.
| 12697010PubMed |
[31] Grayson ML, Melvani S, Kirsa SW, Cheung S, Korman AM, Garrett MK, Thomson WA. Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital. Med J Aust 2004; 180 455–8.
| 15115423PubMed |
[32] Nouwen JL. Controlling antibiotic use and resistance. Clin Infect Dis 2006; 42 776–7.
| Controlling antibiotic use and resistance.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD28%2FptVShsg%3D%3D&md5=9da81ee96cf3f8d1eb6d7beb8d966691CAS | 16477552PubMed |
[33] Marwick CA, Nathwani D. Improving antimicrobial prescribing through knowledge and skills. J Antimicrob Chemother 2007; 59 819–20.
| Improving antimicrobial prescribing through knowledge and skills.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXltVKgu74%3D&md5=f1aba260130df758248d76111a5f65bcCAS | 17283032PubMed |
[34] James R, McIntosh K, Luu S, Cotta M, Marshall C, Thursky KA, Buising KL. Antimicrobial stewardship survey in Victorian hospitals: a state-wide survey to identify current gaps. Med J Aust 2013; 199 692–5.
| 24237101PubMed |
